top of page

THEMISMED and IOLCP rewarded by CARE Ratings for its improved performance

Updated: Jul 6, 2021


CARE Ratings Limited ('CARE') has upgraded long term credit rating on the company's bank facilities to B+ Stable, from B Stable for Themis Medicare and A+ Stable from A Stable for IOL chemical & pharmaceuticals.


Themis Medicare :


Themis Medicare Limited is engaged in manufacturing pharmaceuticals and medicinal chemicals, such as formulations and active pharmaceutical ingredients.



Companies Net Sales Up 33.84% by Rs 61.77 crore in March 2021 from Rs.46.15 crore in March 2020. Quarterly Net profit up 10.67 % by Rs.8.05 crore in March 2021 from Rs.7.28 crore in March 2020. EBITDA down 4.65 % by Rs.13.13 crore in March 2021 from Rs.13.77 crore in March 2020. EPS has increased to Rs. 8.76 in March 2021 from Rs. 7.92 in March 2020.



IOL chemical & pharmaceuticals:


IOL Chemicals and Pharmaceuticals Limited is a pharmaceutical company. The Company is engaged in manufacturing and selling of organic chemicals and bulk drugs.


Companies Net Sales up 17% by Rs. 460.38 crore in March 2021 from Rs.441.46 crore in March 2020. Quarterly Net profit down 17% by Rs.75 crore in March 2021 from Rs.90 crore in March 2020. EBITDA down 18% by Rs.117 crore in March 2021 from Rs.142 crore in March 2020. EPS has decreased to Rs. 12.76 in March 2021 from Rs. 15.87 in March 2020.





 
 
 

Comentarios


Subscribe Form

Thanks for submitting!

  • Facebook
  • Twitter
  • LinkedIn

©2021 by chipperstocks.

bottom of page